| Guideline | Drug Name |
|---|---|
| Tremfya (guselkumab) | Tremfya IV (guselkumab), Tremfya SC (guselkumab) |
| Tukysa (tucatinib) | Tukysa (tucatinib) |
| Turalio (pexidartinib) | Turalio (pexidartinib) |
| Tykerb (lapatinib) | Tykerb (lapatinib) |
| Tysabri (natalizumab) | Tysabri (natalizumab) |
| Ultomiris (ravulizumab-cwvz) | Ultomiris (ravulizumab-cwvz) |
| Unituxin (dinutuximab) | Unituxin (dinutuximab) |
| Ustekinumab | Stelara IV (ustekinumab), Wezlana IV (ustekinumab-auub), Stelara SC (ustekinumab), Wezlana SC (ustekinumab-auub) |
| Venclexta (venetoclax) | Venclexta (venetoclax) |
| Veopoz (pozelimab-bbfg) | Veopoz (pozelimab-bbfg) |
| Verzenio (abemaciclib) | Verzenio (abemaciclib) |
| Vimizim (elosulfase alfa) | Vimizim (elosulfase alfa) |
| Voranigo (Vorasidenib) | Voranigo (Vorasidenib) |
| Votrient (pazopanib) | Votrient (pazopanib) |
| Vyndaqel (tafamidis meglumine), Vyndamax (tafamidis) | Vyndaqel (tafamidis meglumine), Vyndamax (tafamidis) |
| Vyxeos (daunorubicin and cytarabine) | Vyxeos (daunorubicin and cytarabine) |
| Wegovy cardiovascular risk reduction-EHB | Wegovy (semaglutide) |
| Xalkori (crizotinib) - PA, NF | Xalkori (crizotinib) |
| Xdemvy (lotilaner) PA, NF | Xdemvy (lotilaner ophthalmic solution) |
| Xeljanz, Xeljanz XR (tofacitinib) | Xeljanz (tofacitinib) tablets and oral solution, Xeljanz (tofacitinib) tablets, Xeljanz XR (tofacitinib) extended-release tablets |
-
Our PlansShop PlansCompare Plans
-
Search Doctors
-
PharmacyPrescription Coverage
-
WHA Provider
-
Health & WellnessHealthy LivingResources
-
Other Sites
HEALTHY LIVING